EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Using Traveler-based Genomic Surveillance at 4 US Airports, September 2021–January 2022

Renee D Wegrzyn, Grace D Appiah, Robert Morfino, Scott R Milford, Allison Taylor Walker, Ezra T Ernst, William W Darrow, Siyao Lisa Li, Keith Robison, Duncan MacCannell, Dongjuan Dai, Brintha P Girinathan und 9 weitere

Clinical Infectious Diseases · 08.02.2023 · 76 (3) · e540-e543

DOI: 10.1093/cid/ciac461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 06.07.2022. Verfasst von Renee D Wegrzyn und 20 weiteren Autor:innen. Beteiligte Einrichtung: Ginkgo Bioworks, Inc, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CDC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We enrolled arriving international air travelers in a severe acute respiratory syndrome coronavirus 2 genomic surveillance program. We used molecular testing of pooled nasal swabs and sequenced positive samples for sublineage. Traveler-based surveillance provided early-warning variant detection, reporting the first US Omicron BA.2 and BA.3 in North America.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansAirportsGenomics

Stichwörter der Autor:innen

SARS-CoV-2genomic surveillanceinternational travelers

Autor:innen und Institutionen

  • Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
  • Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • XpresCheck™, XpresSpa™, New York, NY, USA.
  • Office of Advanced Molecular Detection, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Förderung

  • CDC

Zitieren

APA

Wegrzyn, R. D., Appiah, G. D., Morfino, R., Milford, S. R., Walker, A. T., Ernst, E. T., Darrow, W. W., Li, S. L., Robison, K., MacCannell, D., Dai, D., Girinathan, B. P., Hicks, A. L., Cosca, B., Woronoff, G., Plocik, A. M., Simen, B. B., Moriarty, L., Guagliardo, S. A. J., …, & Friedman, C. R. (2023). Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Using Traveler-based Genomic Surveillance at 4 US Airports, September 2021–January 2022. Clinical Infectious Diseases, 76(3), e540-e543. https://doi.org/10.1093/cid/ciac461

Vancouver

Wegrzyn RD, Appiah GD, Morfino R, Milford SR, Walker AT, Ernst ET, et al. Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Using Traveler-based Genomic Surveillance at 4 US Airports, September 2021–January 2022. Clinical Infectious Diseases. 2023;76(3):e540-e543. doi:10.1093/cid/ciac461

BibTeX
@article{Wegrzyn2023,
  author = {Wegrzyn, Renee D and Appiah, Grace D and Morfino, Robert and Milford, Scott R and Walker, Allison Taylor and Ernst, Ezra T and Darrow, William W and Li, Siyao Lisa and Robison, Keith and MacCannell, Duncan and Dai, Dongjuan and Girinathan, Brintha P and Hicks, Allison L and Cosca, Bryan and Woronoff, Gabrielle and Plocik, Alex M and Simen, Birgitte B and Moriarty, Leah and Guagliardo, Sarah Anne J and Cetron, Martin S and Friedman, Cindy R},
  title = {Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Using Traveler-based Genomic Surveillance at 4 US Airports, September 2021–January 2022},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {3},
  pages = {e540--e543},
  doi = {10.1093/cid/ciac461}
}
Kostenlos starten →